SkyAI (SKYA) risk factors, FY2025 10-K

SkyAI's FY2025 10-K, filed Mar 31, 2026, lists 46 risk factors in 4 groups. Against the prior year's 27: 29 new, 10 dropped, 6 substantially reworded.

Open SKYA in Gloom →
SkyAI's chart, financials and news, free in your browser.Open SKYA in Gloom →
Risk factors listed
464 groups
New this year
29vs 27 last year
Dropped
10since the prior 10-K
Substantially reworded
6of those kept
Section length
11k wordsItem 1A

What the changes say

  • SkyAI shifted its business strategy to include a digital asset treasury focused on Solana (SOL).
  • Net losses surged to $282.5 million in 2025 alongside 2,000,000 SOL holdings.

What changed since the prior 10-K

New

  • New

    Summary of Significant Risks Affecting Our Company

  • New

    The slowing or stopping of the development or acceptance of Solana and other cryptocurrency networks may adversely affect an investment in us

    The slowing or stopping of the development or acceptance of Solana and other cryptocurrency networks may adversely affect an investment in us.

  • NewRisks Related to Our Technology, Business, and Industry

    We may not succeed in selling and distributing syringes

    We may face difficulties or delays in selling and distributing syringes due to marketing hurdles or an inability to attract and retain a sales force.

  • NewRisks Related to Ownership of Our Common Stock

    The price of our Common Stock has been and may continue to be volatile and fluctuate substantially, which could result in substantial losses for purchasers of our Common Stock

    The adoption of our new SOL Treasury Policy is expected to cause additional volatility in our Common Stock price.

  • NewRisks Related to Ownership of Our Common Stock

    Our financial results and the market price of our Common Stock may be affected by the prices of SOL

    We hold approximately 2,000,000 SOL, exposing us to dramatic price fluctuations, regulatory uncertainties, and adverse developments specific to Solana.

  • NewRisks Related to Ownership of Our Common Stock

    If securities analysts do not publish research or reports about our business or if they publish negative, or inaccurate, evaluations of our Common Stock, the price of our stock and trading volume could decline

    If securities analysts publish negative or inaccurate evaluations of our Common Stock or SOL Treasury Policy, our stock price could decline.

  • NewRisks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

    The digital asset trading platforms on which cryptocurrency trades are relatively new and largely unregulated or may not be complying with existing regulations

    Digital asset trading platforms through which SOL trades are new, largely unregulated, and may restrict withdrawals or impose transaction limits.

  • NewRisks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

    We may be unable to successfully implement our digital asset treasury strategy with a focus on SOL

    Our SOL-focused strategy involves staking and decentralized finance activities, requiring specialized employee skillsets and operational infrastructure under limited regulatory guidance from the SEC.

  • NewRisks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

    Our shift towards a SOL-focused strategy requires substantial changes in our day-to-day operations and exposes us to significant operational risks

    Operating validator nodes and staking SOL requires constant uptime and exposes us to operational and cybersecurity risks.

  • NewRisks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

    Our concentration in a single digital asset exposes us to unique liquidity risks that may prevent us from converting SOL into fiat currency or other assets when desired, particularly during periods of market stress

    Our concentration in SOL exposes us to liquidity risks that may prevent us from converting digital assets into fiat currency during market stress.

  • NewRisks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

    A disruption of the Internet may affect the operation of the cryptocurrency networks, which may adversely affect the cryptocurrency industry and an investment in us

    A disruption of the Internet or border gateway protocol hijacking could disrupt cryptocurrency networks and negatively impact our stock value.

  • NewRisks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

    Blockchain technologies are based on theoretical conjectures as to the impossibility of solving certain cryptographical puzzles quickly. These premises may be incorrect or may become incorrect due to technological advances

    Mathematical advances or quantum computers could undermine the cryptographic consensus mechanism underpinning the Solana network.

  • NewRisks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

    Technical shortcomings or defects in the Solana network, including changes to its validator structure, governance model, or core software, could diminish the utility and value of SOL and harm our business

  • NewRisks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

    If validators exit the Solana network, it could increase the likelihood of a malicious actor obtaining control

  • NewRisks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

    We face risks relating to the potential compromise of the Solana network and other cryptocurrencies’ network security by emerging technologies, including artificial intelligence and quantum computing, which may materially and adversely impact our operations and financial condition

  • NewRisks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

    The trading prices of many digital assets, including SOL, have experienced extreme volatility in recent periods and may continue to do so. Extreme volatility in the future, including further declines in the trading prices of SOL, could have a material adverse effect on the value of the Common Stock

  • NewRisks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

    Our management may invest or otherwise use the proceeds of any offering by us in ways with which you may not agree or in ways that may not yield a return

  • NewRisks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

    If we lose key personnel, including our Chief Investment Officer, Consultant and Strategic Advisor, or if we fail to recruit additional highly skilled personnel, our ability to operate and manage our digital asset treasury strategy will be impaired

  • NewRisks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

    Conflicts of interest may arise with our Consultant and Strategic Advisor that may adversely affect our operations

  • NewRisks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

    If we are unable to raise additional capital on acceptable terms, our ability to implement and sustain our Treasury Policy may be compromised

  • NewRisks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

    Our SOL holdings are less liquid than our existing cash and cash equivalents and may not be able to serve as a source of liquidity for us to the same extent as cash and cash equivalents

  • NewRisks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

    Our Staking Program involves a temporary loss of Transferability of Staked SOL during the “deactivation” or Cooldown Period

  • NewRisks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

    We may be subject to regulatory developments related to crypto assets and crypto asset markets, which could adversely affect our business, financial condition, and results of operations

  • NewRisks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

    Future tax legislation or regulatory guidance regarding digital assets, including the treatment of staking rewards, could materially affect our financial condition and results of operations

  • NewRisks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

    Regulatory change reclassifying SOL as a security could lead to our falling within the definition of “investment company” under the Investment Company Act of 1940, as amended (the “1940 Act”), and could adversely affect the market price of SOL and the market price of our Common Stock

  • NewRisks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

    We are not subject to legal and regulatory obligations that apply to investment companies such as mutual funds and exchange-traded funds, or to obligations applicable to investment advisers

  • NewRisks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

    Our classification as a digital asset treasury company may affect our eligibility for inclusion in stock indices and exchange-traded funds, which could adversely affect the trading price and liquidity of our Common Stock

  • NewRisks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

    We rely on third-party custodians, trading platforms, and other counterparties to acquire, secure, stake, and dispose of SOL. Any failure or malfeasance by these counterparties could result in total or partial loss of our digital assets

  • NewRisks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

    We face other risks related to our SOL treasury reserve business model

Dropped

  • DroppedRisks Related to Our Technology, Business, and Industry

    We may not succeed in commercializing Sharps Provensa products or any future product

  • DroppedRisks Related to Our Technology, Business, and Industry

    In addition, to increase our production capacity, we will need to build inventory, which will require that we purchase certain additional equipment, including molding machines and molds. We have had no revenues to date

  • DroppedRisks Related to Our Technology, Business, and Industry

    We are vulnerable to new technologies

    Difficulties in commercializing Sharps Provensa products.

  • DroppedRisks Related to Our Technology, Business, and Industry

    Ongoing regulation of our products may limit how we market our products, which could materially impair our ability to generate revenue

    Need to build inventory and purchase molding machines.

  • DroppedRisks Related to Our Technology, Business, and Industry

    Health care crises could have an adverse effect on our business

  • DroppedRisks Related to Our Technology, Business, and Industry

    Our business may be adversely affected by uncertainties in obtaining and enforcing intellectual property rights

    Vulnerability to new technologies and competing safety needle products.

  • DroppedRisks Related to Our Technology, Business, and Industry

    Our patent pending applications may not issue as patents, which may have a material adverse effect on our ability to prevent others from commercially exploiting products similar to ours

  • DroppedRisks Related to Our Technology, Business, and Industry

    Illegal distribution and sale by third parties of counterfeit versions of our products could have a negative impact on us

  • DroppedRisks Related to Our Securities

    Our common stock could be subject to extreme volatility

    Ongoing regulation of products limiting marketing and patient population.

  • DroppedRisks Related to Our Securities

    Additional stock offerings in the future may dilute then-existing shareholders’ percentage ownership of the Company

Reworded

  • 83% rewrittenRisks Related to Our Technology, Business, and Industry

    Our business may be affected by changes in the health care regulatory environment

    Updated to apply healthcare regulatory risks to syringes and medical devices rather than general product demand.

  • 82% rewrittenRisks Related to Ownership of Our Common Stock

    Our shares will be subject to potential delisting if we do not maintain the listing requirements of the Nasdaq Capital Market

    Retained Nasdaq delisting risk text with no substantive wording changes.

  • 77% rewrittenRisks Related to Our Technology, Business, and Industry

    We are an early-stage company with a history of losses

    Net losses increased from $9.3 million in 2024 to $282.5 million in 2025, with an accumulated deficit of $316.9 million, and added risks regarding SOL operations.

  • 55% rewrittenRisks Related to Our Technology, Business, and Industry

    We may encounter significant competition and may not be able to successfully compete

    Removed specific competitor names and updated language from commercializing disposable syringe products to selling and distributing syringes.

  • 40% rewrittenRisks Related to Our Technology, Business, and Industry

    We are subject to product liability risk

    Removed the specific $5 million figure for product liability coverage.

  • 32% rewrittenRisks Related to Our Technology, Business, and Industry

    We have a limited operating history and we may not succeed

    Updated operating history to state the company formerly manufactured and commercialized syringe products and now solely sells and distributes them.

All 46 risk factors

Headings as the filing states them, in filing order.

Other

  1. 01Summary of Significant Risks Affecting Our CompanyNew
  2. 02The slowing or stopping of the development or acceptance of Solana and other cryptocurrency networks may adversely affect an investment in usNew

Risks Related to Our Technology, Business, and Industry

  1. 03We are an early-stage company with a history of losses77% rewritten
  2. 04We have a limited operating history and we may not succeed32% rewritten
  3. 05We may not succeed in selling and distributing syringesNew
  4. 06We may encounter significant competition and may not be able to successfully compete55% rewritten
  5. 07We are subject to product liability risk40% rewritten
  6. 08Our business may be affected by changes in the health care regulatory environment83% rewritten
  7. 09We are dependent on our management; without whose services our business operations could cease
  8. 10We may not be able to raise capital as needed to develop our products or maintain our operations

Risks Related to Ownership of Our Common Stock

  1. 11The price of our Common Stock has been and may continue to be volatile and fluctuate substantially, which could result in substantial losses for purchasers of our Common StockNew
  2. 12Our financial results and the market price of our Common Stock may be affected by the prices of SOLNew
  3. 13If securities analysts do not publish research or reports about our business or if they publish negative, or inaccurate, evaluations of our Common Stock, the price of our stock and trading volume could declineNew
  4. 14We have never paid common stock dividends and have no plans to pay dividends in the future, as a result our common stock may be less valuable because a return on an investor’s investment will only occur if our stock price appreciates
  5. 15Our shares will be subject to potential delisting if we do not maintain the listing requirements of the Nasdaq Capital Market82% rewritten
  6. 16We incur increased costs as a result of operating as a public company, and our management is required to devote substantial time to compliance with our public company responsibilities and corporate governance practices
  7. 17As a result of being a public company, we are obligated to develop and maintain proper and effective internal controls over financial reporting, and any failure to maintain the adequacy of these internal controls may adversely affect investor confidence in our company and, as a result, the value of our common stock
  8. 18A sale of a substantial number of shares of our common stock may cause the price of the common stock to decline
  9. 19Our stock price may be volatile, and the value of our common stock may decline
  10. 20We do not intend to pay dividends on our common stock for the foreseeable future
  11. 21Our articles of incorporation allow for our board to create new series of preferred stock without further approval by our stockholders, which could adversely affect the rights of the holders of our common stock
  12. 22Future securities issuances could result in significant dilution to our stockholders and impair the market price of our common stock
  13. 23We are an “emerging growth company,” and we cannot be certain if the reduced reporting and disclosure requirements applicable to emerging growth companies will make our common stock less attractive to investors

Risks Related to Our Digital Asset Trading Strategy and Cryptocurrencies

  1. 24The digital asset trading platforms on which cryptocurrency trades are relatively new and largely unregulated or may not be complying with existing regulationsNew
  2. 25We may be unable to successfully implement our digital asset treasury strategy with a focus on SOLNew
  3. 26Our shift towards a SOL-focused strategy requires substantial changes in our day-to-day operations and exposes us to significant operational risksNew
  4. 27Our concentration in a single digital asset exposes us to unique liquidity risks that may prevent us from converting SOL into fiat currency or other assets when desired, particularly during periods of market stressNew
  5. 28A disruption of the Internet may affect the operation of the cryptocurrency networks, which may adversely affect the cryptocurrency industry and an investment in usNew
  6. 29Blockchain technologies are based on theoretical conjectures as to the impossibility of solving certain cryptographical puzzles quickly. These premises may be incorrect or may become incorrect due to technological advancesNew
  7. 30Technical shortcomings or defects in the Solana network, including changes to its validator structure, governance model, or core software, could diminish the utility and value of SOL and harm our businessNew
  8. 31If validators exit the Solana network, it could increase the likelihood of a malicious actor obtaining controlNew
  9. 32We face risks relating to the potential compromise of the Solana network and other cryptocurrencies’ network security by emerging technologies, including artificial intelligence and quantum computing, which may materially and adversely impact our operations and financial conditionNew
  10. 33The trading prices of many digital assets, including SOL, have experienced extreme volatility in recent periods and may continue to do so. Extreme volatility in the future, including further declines in the trading prices of SOL, could have a material adverse effect on the value of the Common StockNew
  11. 34Our management may invest or otherwise use the proceeds of any offering by us in ways with which you may not agree or in ways that may not yield a returnNew
  12. 35If we lose key personnel, including our Chief Investment Officer, Consultant and Strategic Advisor, or if we fail to recruit additional highly skilled personnel, our ability to operate and manage our digital asset treasury strategy will be impairedNew
  13. 36Conflicts of interest may arise with our Consultant and Strategic Advisor that may adversely affect our operationsNew
  14. 37If we are unable to raise additional capital on acceptable terms, our ability to implement and sustain our Treasury Policy may be compromisedNew
  15. 38Our SOL holdings are less liquid than our existing cash and cash equivalents and may not be able to serve as a source of liquidity for us to the same extent as cash and cash equivalentsNew
  16. 39Our Staking Program involves a temporary loss of Transferability of Staked SOL during the “deactivation” or Cooldown PeriodNew
  17. 40We may be subject to regulatory developments related to crypto assets and crypto asset markets, which could adversely affect our business, financial condition, and results of operationsNew
  18. 41Future tax legislation or regulatory guidance regarding digital assets, including the treatment of staking rewards, could materially affect our financial condition and results of operationsNew
  19. 42Regulatory change reclassifying SOL as a security could lead to our falling within the definition of “investment company” under the Investment Company Act of 1940, as amended (the “1940 Act”), and could adversely affect the market price of SOL and the market price of our Common StockNew
  20. 43We are not subject to legal and regulatory obligations that apply to investment companies such as mutual funds and exchange-traded funds, or to obligations applicable to investment advisersNew
  21. 44Our classification as a digital asset treasury company may affect our eligibility for inclusion in stock indices and exchange-traded funds, which could adversely affect the trading price and liquidity of our Common StockNew
  22. 45We rely on third-party custodians, trading platforms, and other counterparties to acquire, secure, stake, and dispose of SOL. Any failure or malfeasance by these counterparties could result in total or partial loss of our digital assetsNew
  23. 46We face other risks related to our SOL treasury reserve business modelNew

Other SkyAI 10-Ks

  • FY2024 10-K risk factors
    27 risks

    SkyAI is an early-stage medical device company facing multi-million dollar losses and zero revenue to date. The business depends entirely on successfully commercializing Securgard, Sologard, and Sharps Provensa safety syringes. Strict healthcare regulations, intellectual property protection, and substantial capital raising needs dominate the risk profile.

    Filed Mar 27, 2025

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.